Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
INTRODUCTION. Adrenal crisis refers to acute adrenal insufficiency; which is a disorder in which the adrenal cortex does not produce enough steroid hormones (especially cortisol) to meet the body’s demands, according to the pathophysiological mechanism it can be classified as primary, secondary and tertiary, being more common in patients with primary adrenal insufficiency. It is a life-threatening emergency that requires immediate treatment. OBJECTIVE. To establish a strategy for the prevention and treatment of adrenal crisis, as well as the ideal pharmacotherapy and its valid alternatives. MATERIAL AND METHODS. A literature review was performed in several highly scientific virtual journals such as Cochrane Library, Cochrane Systematic
Reviews Database, MEDLINE through PubMed and ClinicalTrial.gov. Systematic reviews with or without meta-analysis, clinical trials and expert recommendations related to prevention and treatment of adrenal crisis in general were selected. RESULTS. A total of 1819 results were obtained, from which 20 articles with greater validity and replicability in the setting were selected to establish a unified protocol for action.
CONCLUSIONS. The aim of therapy is the treatment of hypotension and reversal of electrolyte abnormalities and cortisol deficiency. Large volumes (1 to 3 liters) of 0.9% saline or 5% dextrose in 0.9% saline and administration of hydrocortisone (100 mg bolus), followed by 50 mg every 6 hours (or 200 mg / 24 hours as a continuous infusion for the first 24 hours) should be infused intravenously. If hydrocortisone is not
available, alternatives include prednisolone, prednisone, and dexamethasone.
Grossman AB. The Diagnosis and Management of Central Hypoadrenalism. 10 Nov. 2010. J Clin Endocrinol & Metab: 4855-4863. Available from:https://academic.oup.com/jcem/article/95/11/4855/2835169
Crown A, Lightman Stanfford. Why is the management of glucocorticoid deficiency still controlversial: a review of the literature. Clin Endocrinol (Oxf). Nov 2005: 63(5): 483-492. Available from: https://pubmed.ncbi.nlm.nih.gov/16268798/
Bliesener N, Steckelbroeck L; Dlingmuller D. Dose distribution in hydrocortisone replacement therapy has a significant influence on urine free cortisol excretion. Oct 2003. Exp Clin Endocrinol Diabetes. 44292. Available from: https://pubmed.ncbi.nlm.nih.gov/14614652/
Choudhury S, Lightman S, Meeran K.Improving glucocorticoid replacement profiles in adrenal insufficiency. Clin Endocrinol (Oxf), 2019: 367-371. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1111/cen.13999
Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2016. 101: 364-389. Available from: https://mayoclinic.pure.elsevier.com/en/publications/diagnosis-and-treatment-of-primary-adrenal-insufficiency-an-endoc
Hahner S, Loeffler M, Fassnacht M, et al. (2007). Impaired subjective health status in 256 patients with adrenal insufficency on standard therapy base on cros-sectional analysis. J Clin Endocrinol Metab , Oct 2007: 92(10): 3912-22 Available from: https://pubmed.ncbi.nlm.nih.gov/17684047/.
Johannsson G, Nilsson AG, Bergthorsdottir R, et al. (2012). Mejor perfil de exposición al cortisol-tiempo y resultado en pacientes con insuficiencia suprarrenal: un ensayo aleatorizado prospectivo de una nueva formulación de hidrocortisona de liberación dual. J Clin Endocrinol Metab, Feb 2012: 97 (2): 473-481. Available from: https://pubmed.ncbi.nlm.nih.gov/22112807/
Løvås K, Gjesdal CG, Christensen M, et al. Terapia de reemplazo de glucocorticoides y farmacogenética en la enfermedad de Addison: efectos sobre el hueso. Eur J Endocrinol, Jun 2009: 160 (6): 993-1002. Available from: https://pubmed.ncbi.nlm.nih.gov/19282465/
Whitaker MJ, Debono M, Huatan H, Merke D, Wiebke A, Ross RJ. An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure. Clin Endocrinol (Oxf), 80(4): 554-561. Available from: https://pubmed.ncbi.nlm.nih.gov/23980724/
Puar THK, Stikkelbroeck NMML, Smans LCCJ, Zelissen PMJ, et al. Adrenal crisis: still a deadly event in the 21st Century. Am J Med 2016; 129 (3): 339e1-9. Available from: DOI. 10.1016/j. amjmed.2015.08.021.
Hashim, Maram; Athar, Syed; Gaba, Waqar Haider. BMJ Case Rep ; 14(1)2021 Jan 18. New onset adrenal insufficiency in a patient with COVID-19.MEDLINE | ID: covidwho-1066835. Available from: https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/es/covidwho-1066835
Ho W, D. M. (2018). Quality of life in patients with adrenal diseases: A systematic review. Clin Endocrinol (Oxf), 89: 119. Available from: https://pubmed.ncbi.nlm.nih.gov/29672878/
Wiebke, A. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab, 2009: 94(4): 1059-67. Available from: https://pubmed.ncbi.nlm.nih.gov/19349469/
Hussain S, Hussain S, Mohammed R, Karim M, Nazim G. Fasting with adrenal insufficiency: Practical guidance for healthcare professionals managing patients on steroids during Ramadan. . Clin Endocrinol (Oxf) , Aug 2020: 93(2):87-96. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/cen.14250
Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. 2015 Mar;3(3):216-26. Available from: https://pubmed.ncbi.nlm.nih.gov/25098712/
Esteban NV, Loughlin T, Yergey AL, et al.Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab, 1991.72: 39–45. Available from: https://pubmed.ncbi.nlm.nih.gov/1986026/
Kerrigan JR, Veldhuis JD, Leyo SA, et al. Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab, 1993; 76: 1505–1510. Available from: https://pubmed.ncbi.nlm.nih.gov/8501158/
Rice SP, Agarwal N, Bolusani H, et al. (2009). Effects of dehydroepianddrosterone replacement on vascular function in primary and secondary adrenal inssufficiency: a randomized crossover trial. J Clin Endocrinol Metab. Jun 2009, 94(6): 1966-72. Available from: https://pubmed.ncbi.nlm.nih.gov/19318448
Srinivasan M, Irving BA, Dhatariya K, et al. Effect of Dehydroepiandrosterone Replacement on Lipoprotein Profile in Hypoadrenal Women. 2009. J Clin Endocrinol Metab , 94: 761. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681274/
Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, et al. (2015). High Incidence of Adrena Crisis in Educated Patients with chronic adrenal insuffiency: A prospective study. J Clin Endocrinol Metab. Feb 2015. Vol. 100 (2): 407-416. Available from: https://academic.oup.com/jcem/article/100/2/407/2813314
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.